- English (UK)
- English (India)
- English (Canada)
- English (Australia)
- English (South Africa)
- English (Philippines)
- English (Nigeria)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Polski
- Português (Portugal)
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
Pfizer Inc (PFE)
NYSE
Symbol | Exchange | Currency | |||
|---|---|---|---|---|---|
| PFE | · | NYSE | · | USD | |
| PFE | · | Xetra | · | EUR | |
| PFECHF | · | Switzerland | · | CHF | |
| 1PFE | · | Milan | · | EUR | |
| PFE | · | Vienna | · | EUR | |
| PFEm | · | Buenos Aires | · | ARS | |
| PFE | · | Santiago | · | USD | |
| PFIZ34 | · | B3 | · | BRL | |
| PFE | · | Toronto | · | CAD | |
| PFE | · | Mexico | · | MXN | |
| PFECO | · | Colombia | · | COP | |
| PFEUS | · | Lima | · | USD | |
| PFE | · | Ukraine | · | UAH | |
| PFE | · | Frankfurt | · | EUR | |
| PFE | · | TradeGate | · | EUR | |
| PFE_KZ | · | KASE | · | USD | |
| PFE_KZTQBD | · | KASE | · | USD | |
| PFE | · | Hamburg | · | EUR | |
| PFE | · | CBOE Canada | · | CAD |
Currency in USD
28.02
+0.52(+1.87%)
Real-time Data·
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
27.55
28.17
52 wk Range
23.62
29.21
PFE Comments
Compiled here, all relevant comments and discussions regarding the PFE stock. Please note that all comments included here have met Investing.com's Comment Guidelines.
junk. don't waste your money.
Time to buy
Long $PFE @ 27.86.
Why dividends still not received
Why dividends still not received
speculate on what the top investors will do
The situation may not be great, but it's what we have
Pfizer promoter "I represent the Science" Fauci pled the 5th over 100 times because he was afraid to answer questions regarding his pandemic advice. Not a good look.
the company should buyback its shares.
Take the 7 percent and run !!
The only thing this stock has is Dividend, it never goes up, tired of keeping this
Need another pandemic
It may be ironic, but while banks are extremely leveraged, this is a less leveraged company that continues to generate acceptable returns.
It's a perfect bank to park your money.
Because of the dividend
These rules—which I realize must be followed as basic accounting principles—compound the problems related to patents and commercial competition. This can get very tedious, but it’s the reality, and a dose of reality has never hurt us.
What is keeping Pfizer's stock price low is the major pending legal case, in addition to other expenses and costs that are expected to arise in the future and need to be budgeted for.
This might be considered conformism, but it is undoubtedly an expansion of my support base.
I prefer to consolidate my position a little higher up and face the vicissitudes of reality.
Working hard to get a new yearly low. I guess they will let this current leadership continue to destroy this company.
1062244650
jumping ship. New leadership at the top may be a good thing. can not be much worse than the current leadership.
Nobody is talking about this high dividend company, I think PFE and At&T should be bought and forget for 20 yes to come.
Totally agree with you.
I'm afraid we will see $24 before we see $30. No real gains until changes at the top.
I think it will go up next as I expect $30
The only thing this stock has is Dividend And nothing can move it higher
Pfizer is a heavy rock. Good news doesn't change anything
...
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.